BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31678981)

  • 1. Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient.
    Tang J; Ma W; Luo L
    Med Sci Monit; 2019 Nov; 25():8248-8259. PubMed ID: 31678981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
    Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L
    Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
    Zhang Q; Xia T; Qi C; Du J; Ye C
    BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients.
    Bian Z; Huang X; Chen Y; Meng J; Feng X; Zhang M; Zhang L; Zhou J; Liang C
    Int J Med Sci; 2021; 18(1):284-294. PubMed ID: 33390797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Key Prognostic-Related miRNA-mRNA Pairs in the Progression of Endometrial Carcinoma.
    Dong Y; Zhang T; Li X; Yu F; Yu H; Shao S
    Gynecol Obstet Invest; 2022; 87(1):12-21. PubMed ID: 35081534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
    Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
    Gene; 2019 May; 697():86-93. PubMed ID: 30779946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel necroptosis-associated miRNA signature predicting prognosis of endometrial cancer and correlated with immune infiltration.
    Ye Z; Jiang Y; Wu J
    Taiwan J Obstet Gynecol; 2023 Mar; 62(2):291-298. PubMed ID: 36965898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma.
    Ouyang D; Li R; Li Y; Zhu X
    Med Sci Monit; 2019 Oct; 25():7998-8010. PubMed ID: 31650984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
    Lai J; Xu T; Yang H
    BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatic analysis of differentially expressed profiles of lncRNAs and miRNAs with their related ceRNA network in endometrial cancer.
    Li F; Zhou C; Li S; Wang J; Li M; Mu H
    Medicine (Baltimore); 2023 Jan; 102(3):e32573. PubMed ID: 36701720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients.
    Qian J; Zeng L; Jiang X; Zhang Z; Luo X
    Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
    Yang Q; Yu B; Sun J
    Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
    Zhang X; Zhang M; Zhang X; Zhu X; Wang J
    BMC Med Inform Decis Mak; 2020 Jul; 20(Suppl 3):136. PubMed ID: 32646427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
    Zhang J; Wang Z; Zhao R; An L; Zhou X; Zhao Y; Wang H
    BMC Cancer; 2020 Oct; 20(1):1030. PubMed ID: 33109128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
    Wang P; Zeng Z; Shen X; Tian X; Ye Q
    DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Five-MicroRNA Signature Model for the Prediction of Prognosis in Patients with Wilms Tumor.
    Gong Y; Zou B; Chen J; Ding L; Li P; Chen J; Chen J; Zhang B; Li J
    Med Sci Monit; 2019 Jul; 25():5435-5444. PubMed ID: 31328722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.